Ocugen OCGN Stock
Ocugen Price Chart
Ocugen OCGN Financial and Trading Overview
| Ocugen stock price | 1.23 USD |
| Previous Close | 0.5 USD |
| Open | 0.5 USD |
| Bid | 0 USD x 4000 |
| Ask | 0 USD x 1800 |
| Day's Range | 0.49 - 0.54 USD |
| 52 Week Range | 0.44 - 3.11 USD |
| Volume | 11.38M USD |
| Avg. Volume | 7.43M USD |
| Market Cap | 137.63M USD |
| Beta (5Y Monthly) | 3.716403 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.32 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.58 USD |
OCGN Valuation Measures
| Enterprise Value | 51.08M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.8506898 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.6020895 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.608 |
Trading Information
Ocugen Stock Price History
| Beta (5Y Monthly) | 3.716403 |
| 52-Week Change | -75.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.11 USD |
| 52 Week Low | 0.44 USD |
| 50-Day Moving Average | 0.65 USD |
| 200-Day Moving Average | 1.25 USD |
OCGN Share Statistics
| Avg. Volume (3 month) | 7.43M USD |
| Avg. Daily Volume (10-Days) | 8.31M USD |
| Shares Outstanding | 256.43M |
| Float | 223.36M |
| Short Ratio | 4.72 |
| % Held by Insiders | 1.74% |
| % Held by Institutions | 40.23% |
| Shares Short | 41.79M |
| Short % of Float | 21.13% |
| Short % of Shares Outstanding | 16.29% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:60 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -44.41% |
| Return on Equity (ttm) | -77.15% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -49757000 USD |
| EBITDA | -84007000 USD |
| Net Income Avi to Common (ttm) | -79830000 USD |
| Diluted EPS (ttm) | -0.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 76.72M USD |
| Total Cash Per Share (mrq) | 0.34 USD |
| Total Debt (mrq) | 6.28M USD |
| Total Debt/Equity (mrq) | 8.28 USD |
| Current Ratio (mrq) | 5.382 |
| Book Value Per Share (mrq) | 0.335 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -63253000 USD |
| Levered Free Cash Flow (ttm) | -41144624 USD |
Profile of Ocugen
| Country | United States |
| State | PA |
| City | Malvern |
| Address | 263 Great Valley Parkway |
| ZIP | 19355 |
| Phone | 484 328 4701 |
| Website | https://www.ocugen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 84 |
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Q&A For Ocugen Stock
What is a current OCGN stock price?
Ocugen OCGN stock price today per share is 1.23 USD.
How to purchase Ocugen stock?
You can buy OCGN shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ocugen?
The stock symbol or ticker of Ocugen is OCGN.
Which industry does the Ocugen company belong to?
The Ocugen industry is Biotechnology.
How many shares does Ocugen have in circulation?
The max supply of Ocugen shares is 356.74M.
What is Ocugen Price to Earnings Ratio (PE Ratio)?
Ocugen PE Ratio is now.
What was Ocugen earnings per share over the trailing 12 months (TTM)?
Ocugen EPS is -0.32 USD over the trailing 12 months.
Which sector does the Ocugen company belong to?
The Ocugen sector is Healthcare.
Ocugen OCGN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}